Skip to main content

Opiate Dependence News (Page 9)

Related terms: Opioid Dependence, Opioid Use Disorder

Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help

MONDAY, Aug. 7, 2023 – The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone,...

FDA Approves Second OTC Naloxone Spray, ReVive, for Suspected Opioid Overdose

THURSDAY, Aug. 3, 2023 – The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid...

Researchers Explore New Nonaddictive Means of Fighting Pain

THURSDAY, Aug. 3, 2023 – New research shows that an experimental drug fine-tuned to a specific pain pathway can ease post-surgery aches, a finding that may eventually offer an alternative to highly...

Oxycodone Does Not Increase Risk for Persistent Opioid Use After Delivery

MONDAY, July 31, 2023 – Initiation of oxycodone versus codeine is not associated with an increased risk for persistent opioid use after delivery overall, but increased risk is seen after vaginal...

With Marijuana's Legalization, Cannabis Poisonings Are on the Rise

THURSDAY, July 27, 2023 – In recent years, the legalization of both medical and recreational marijuana has become the new normal across much of North America. The problem: New research finds that as...

New Opioid Rx Common, Harmful in Older Adults With Dementia

TUESDAY, July 25, 2023 – New opioid use is common among older adults with dementia and is associated with a markedly increased excess mortality, according to a study presented at the annual...

Here's 8 Habits That Could Lengthen Your Life

MONDAY, July 24, 2023 – Eight healthy habits could add years to your life. A new study of more than 700,000 U.S. veterans breaks down the habits that when adopted by middle age, can help someone...

More Rapid Increase Seen in Rate of OD Deaths Involving Cocaine + Opioids

WEDNESDAY, July 19, 2023 – The age-adjusted rate of overdose deaths involving cocaine and opioids increased more quickly from 2011 to 2021 than the rate of overdose deaths involving cocaine alone,...

New Opioid Use Raises Death Risk 11-Fold in Those With Dementia

TUESDAY, July 18, 2023 – Older adults who begin using opioid painkillers after a dementia diagnosis have a significantly greater risk of death — about 11-fold within the first two weeks, according t...

Suicidal Thoughts, Attempts Common Among Patients Starting Buprenorphine

TUESDAY, July 18, 2023 – There is a high prevalence of suicidal thoughts and attempts among patients with opioid use disorder (OUD) initiating buprenorphine, according to a study published online...

FDA Approves Brixadi (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

Plymouth Meeting, Pa. – May 23, 2023—Braeburn announces that the U.S. Food and Drug Administration (FDA) has approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (CIII), a...

FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....

FDA Approves Cassipa (buprenorphine and naloxone) Sublingual Film as Maintenance Treatment for Opioid Dependence

September 7, 2018 – The U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the maintenance treatment of opioid...

FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder

November 30, 2017 – The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use...

FDA Medwatch Alert: Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

ISSUE: Based on additional review, FDA is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Opiate Withdrawal, Opiate Dependence - Maintenance, Drug Dependence

Related drug support groups

Suboxone, Subutex, naltrexone, buprenorphine, Vivitrol, Sublocade, buprenorphine / naloxone